Cyclization of Propargyl Amides
served (reaction monitored by TLC and GC analyses). When the
reaction was complete, the mixture was diluted with EtOAc and
filtered through a short plug of neutral alumina. The filtrate was
washed with aqueous 10% NaHCO3 solution, saturated Na2S2O3
solution, and brine, and dried with Na2SO4. After removal of the
solvent in vacuum, the residue was purified by flash column
chromatography on silica gel (EtOAc/hexanes) to afford the desired
product 5.
1 H) ppm. 13C NMR ([D6]DMSO): δ = 11.7, 122.3, 123.5, 124.2,
147.9, 150.3, 155.0, 168.3 ppm. MS-ESI: m/z = 195 [M + H+], 217
[M + Na+]. C8H6N2O4 (194.14): calcd. C 49.49, H 3.12, N 14.43;
found C 49.40, H 3.10, N 14.39.
3-(5-Methyloxazol-2-yl)-2-phenoxypyridine (5i): 1H NMR (CDCl3):
δ = 2.40 (s, 3 H), 6.93 (s, 1 H), 7.06–7.41 (m, 6 H, ArH), 8.18–8.21
(m, 1 H, ArH) ppm. 13C NMR ([D6]DMSO): δ = 10.7, 112.0, 119.3,
121.4, 124.4, 124.9, 129.6, 139.2, 148.6, 149.8, 153.9, 156.3,
159.2 ppm. MS-ESI: m/z = 253 [M + H+], 275 [M + Na+].
C15H12N2O2 (252.27): calcd. C 71.42, H 4.79, N 11.10; found C
71.36, H 4.82, N 11.08.
Ethyl 5-Benzyl-2-methyloxazole-4-carboxylate (5a): IR (neat): ν =
˜
1
3094, 1743, 1620, 1319, 1109 cm–1. H NMR (CDCl3): δ = 1.40 (t,
J = 7.2 Hz, 3 H), 2.42 (s, 3 H), 4.34 (s, 2 H), 4.40 (q, J = 7.2 Hz,
2 H), 7.26–7.31 (m, 5 H, ArH) ppm. 13C NMR ([D6]DMSO): δ =
13.6, 14.9, 31.0, 62.0, 126.7, 128.2, 129.4, 132.1, 134.9, 150.8, 159.2,
162.0 ppm. MS-ESI: m/z = 246 [M + H+], 268 [M + Na+].
C14H15NO3 (245.11): calcd. C 68.56, H 6.16, N 5.71; found C
68.64, H 6.10, N 5.49.
Benzyl [(5-Methyloxazol-2-yl)methyl]carbamate (5l): IR (neat): ν =
˜
3214, 3063, 1745, 1616, 1315, 1089 cm–1. 1H NMR (CDCl3): δ =
2.40 (s, 3 H), 4.17 (s, 2 H), 4.75 (s, 3 H), 6.93 (s, 1 H), 7.15–7.42
(m, 5 H, ArH) ppm. 13C NMR ([D6]DMSO): δ = 10.9, 34.3, 68.2,
118.4, 127.9, 128.6, 129.0, 136.6, 147.0, 150.5, 161.3 ppm. MS-ESI:
m/z = 247 [M + H+], 269 [M + Na+]. C13H14N2O3 (246.26): calcd.
C 63.40, H 5.73, N 11.38; found C 63.34, H 5.70, N 11.35.
Ethyl
2-[(1,3-Dioxo-2H-benzo[e]isoindolin-2-yl)methyl]oxazole-4-
carboxylate (5b): IR (neat): ν = 3133, 3068, 1730, 1650, 1317,
˜
1
1107 cm–1. H NMR (CDCl3): δ = 1.22 (t, J = 7.2 Hz, 3 H), 3.83
1
5-Benzyl-N,4-diphenyloxazol-2-amine (5n): H NMR (CDCl3): δ =
(s, 2 H), 4.14 (q, J = 7.2 Hz, 2 H), 4.93 (s, 2 H), 6.92 (s, 1 H), 7.78–
7.84 (m, 3 H, ArH), 8.19 (d, J = 8.1 Hz, 1 H, ArH), 8.42–8.45 (m,
1 H, ArH), 8.79 (d, J = 8.1 Hz, 1 H, ArH) ppm. 13C NMR ([D6]-
DMSO): δ = 14.5, 31.4, 34.9, 61.2, 119.0, 125.4, 127.6, 129.7, 130.5,
131.4, 131.7, 136.0, 136.3, 126.7, 146.8, 158.6, 167.0, 167.9,
169.2 ppm. MS-ESI: m/z = 365 [M + H+]. C20H16N2O5 (364.11):
calcd. C 65.93, H 4.43, N 7.69; found C 65.90, H 4.38, N 7.65.
3.41 (s, 2 H), 6.60 (br. s, 1 H, NH), 7.05–7.17 (m, 3 H, ArH), 7.19–
7.34 (m, 8 H, ArH), 7.36–7.41 (m, 4 H, ArH) ppm. 13C NMR ([D6]-
DMSO): δ = 35.6, 116.3, 121.9, 126.3, 127.4, 127.7, 129.3, 129.9,
130.3, 130.8, 131.4, 134.6, 136.8, 138.5, 142.0, 160.8 ppm. MS-ESI:
m/z = 327 [M + H+]. C22H18N2O (326.39): calcd. C 80.96, H 5.56,
N 8.58; found C 80.98, H 5.54, N 8.61.
2-(2,4-Dimethylphenyl)-4,4,5-trimethyl-4,5-dihydrooxazol-5-ol (16):
4-(4-Isopropyl-5-methyloxazol-2-yl)benzonitrile (5c): IR (neat): ν =
IR (neat): ν = 3346, 3098, 1650, 1319, 1074 cm–1. 1H NMR
˜
˜
3068, 2231, 1730, 1319, 1105 cm–1. 1H NMR (DMSO): δ = 1.18 (d,
J = 6.9 Hz, 6 H), 2.35 (s, 3 H), 2.93 (sept, J = 6.9 Hz, 1 H), 7.75–
7.82 (m, 4 H, ArH) ppm. 13C NMR ([D6]DMSO): δ = 10.4, 25.4,
26.1, 112.4, 118.9, 126.4, 131.4, 133.5, 142.4, 144.1, 157.1 ppm.
MS-ESI: m/z = 215 [M + H+], 237 [M + Na+]. C13H14N2O
(214.26): calcd. C 72.87, H 6.59, N 13.07; found C 72.86, H 6.57,
N 13.05.
(CDCl3): δ = 1.60 (s, 6 H), 2.27 (s, 3 H), 2.42 (s, 3 H), 6.53 (br. s,
1 H, OH), 6.99–7.03 (m, 2 H, ArH), 7.25–7.28 (m, 1 H, ArH) ppm.
13C NMR ([D6]DMSO): δ = 19.2, 20.7, 23.3, 23.4, 60.3, 125.9,
127.3, 131.0, 133.4, 135.3, 139.0, 169.1, 208.2 ppm. MS-ESI: m/z =
234 [M + H+], 266 [M + Na+]. C14H19NO2 (233.31): calcd. C 72.07,
H 8.21, N 6.00; found C 72.04, H 8.16, N 5.94.
2-(2,4-Dimethylphenyl)-4,5-dimethyloxazole (5d): IR (neat): ν =
˜
Acknowledgments
1
3073, 1321, 1104 cm–1. H NMR (CDCl3): δ = 2.15 (s, 3 H), 2.30
(s, 3 H), 2.34 (s, 3 H), 2.61 (s, 3 H), 7.02 (d, J = 8.7 Hz, 1 H, ArH),
7.06 (s, 1 H, ArH), 7.80 (d, J = 8.7 Hz, 1 H, ArH) ppm. 13C NMR
([D6]DMSO): δ = 9.6, 11.0, 20.7, 21.4, 123.5, 126.7, 131.1, 132.1,
136.0, 139.0, 142.5, 158.5 ppm. MS-ESI: m/z = 202 [M + H+], 224
[M + Na+]. C13H15NO (201.26): calcd. C 77.58, H 7.51, N 6.96;
found C 77.54, H 7.48, N 6.90.
The authors are grateful to Prof. Marco A. Ciufolini of the Univer-
sity of British Columbia, Vancouver, for many useful suggestions,
and thanks are due to the University of Camerino. S. D. gratefully
acknowledges BI Research Italia for a doctoral fellowship.
[1] T. Eicher, S. Hanptmann, in: The Chemistry of Heterocycles:
Structure, Reactions, Syntheses, and Applications, Wiley-VCH,
Weinheim, Germany, 2003.
[2] G. D. Wright, Chem. Commun. 2011, 4055–4061.
[3] B. Plietker, Synlett 2010, 2049–2058.
[4] a) S. Caddick, R. Fitzmaurice, Tetrahedron 2009, 65, 3325–
3355; b) M. Quai, C. Repetto, W. Barbaglia, E. Cereda, Tetra-
hedron Lett. 2007, 48, 1241–1245.
[5] P. T. Anastas, J. C. Warner, in: Green Chemistry: Theory and
Practice, Oxford University Press, Oxford, UK, 1988.
[6] D. J. Ritson, C. Spiteri, J. E. Moses, J. Org. Chem. 2011, 76,
3519–3522.
5-Benzyl-2,4-diphenyloxazole (5e): IR (neat): ν = 3102, 3069, 1611,
˜
1307, 1109 cm–1. 1H NMR (CDCl3): δ = 4.17 (s, 2 H), 7.20–7.31
(m, 6 H, ArH), 7.39–7.44 (m, 5 H, ArH), 7.82–7.85 (m, 2 H,
ArH) ppm. 13C NMR ([D6]DMSO): δ = 32.2, 120.5, 121.8, 123.0,
125.7, 126.0, 126.3, 126.7, 127.9, 128.0, 128.9, 129.7, 133.0, 134.9,
135.5 ppm. MS-ESI: m/z = 312 [M + H+], 334 [M + Na+].
C22H17NO (311.13): calcd. C 84.86, H 5.50, N 4.50; found C 84.91,
H 5.40, N 4.32.
5-Methyl-2-(2-phenoxyphenyl)oxazole (5g): IR (neat): ν = 3068,
˜
1
3023, 1648, 1317, 1104 cm–1. H NMR (CDCl3): δ = 2.40 (s, 3 H),
[7] a) Z. Jin, Nat. Prod. Rep. 2009, 26, 382–445; b) D. C. Palmer,
E. C. Taylor, in: The Chemistry of Heterocyclic Compounds:
Oxazoles: Synthesis Reaction and Spectroscopy, parts A and B,
Wiley, Hoboken, N. J., 2004, vol. 60.
6.90 (s, 1 H), 7.06–7.10 (m, 1 H, ArH), 7.18–724 (m, 3 H, ArH),
7.26–7.40 (m, 3 H, ArH), 7.92–8.04 (m, 2 H, ArH) ppm. 13C NMR
(CDCl3): δ = 12.9, 116.3, 117.4, 119.0, 121.4, 123.9, 126.4, 127.8,
129.9, 133.0, 146.3, 159.6, 161.0 ppm. MS-ESI: m/z = 252 [M +
H+]. C16H13NO2 (251.27): calcd. C 76.48, H 5.21, N 5.57; found C
76.40, H 5.36, N 5.54.
[8] P. Wipf, Chem. Rev. 1995, 95, 2115–2134.
[9] R. L. Rice, J. M. Rusnak, F. Yokokawa, S. Yokokawa, D.
Messner, A. L. Boynton, P. Wipf, J. S. Lazo, Biochemistry 1997,
36, 15965–15974.
5-Methyl-2-(5-nitro-2-furyl)oxazole (5h): IR (neat): ν = 3033, 1550,
˜
[10] T. E. Smith, W. H. Kuo, E. P. Balskus, V. D. Bock, J. L. Roizen,
A. B. Theberge, K. A. Carroll, T. Kurihara, J. D. Wessler, J.
Org. Chem. 2008, 73, 142–150.
1
1325, 1316, 1109 cm–1. H NMR (CDCl3): δ = 2.48 (s, 3 H), 7.16
(s, 1 H), 7.38–7.40 (d, J = 8.2 Hz, 1 H), 7.82–7.84 (d, J = 8.2 Hz,
Eur. J. Org. Chem. 2012, 630–636
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
635